Glycopyrrolate methobromide. 1. Effect on salivary secretion.
D000704:Analysis of Variance; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D004837:Epinephrine / Q000494:pharmacology; D006024:Glycopyrrolate / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D007552:Isotonic Solutions; D010276:Parasympatholytics / Q000494:pharmacology*; D010306:Parotid Gland / Q000187:drug effects; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012463:Saliva / Q000378:metabolism*; D012636:Secretory Rate / Q000187:drug effects; D012965:Sodium Chloride / Q000494:pharmacology; D013268:Stimulation, Chemical; D013997:Time Factors
D007552:Isotonic Solutions; D010276:Parasympatholytics; D010919:Placebos; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D012965:Sodium Chloride; D001285:Atropine; D002217:Carbachol; D006024:Glycopyrrolate; D004837:Epinephrine